Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy
| dc.contributor.author | Allen, Wendy L. | |
| dc.contributor.author | Dunne, Philip D. | |
| dc.contributor.author | McDade, Simon | |
| dc.contributor.author | Scanlon, Enya | |
| dc.contributor.author | Loughrey, Maurice | |
| dc.contributor.author | Coleman, Helen G. | |
| dc.contributor.author | McCann, Christophe | |
| dc.contributor.author | McLaughlin, Kristy | |
| dc.contributor.author | Nemeth, Zsuzsanna | |
| dc.contributor.author | Syed, Najeeb Ashraf | |
| dc.contributor.author | Jithesh, Puthen Veettil | |
| dc.contributor.author | Arthur, Ken | |
| dc.contributor.author | Wilson, Richard | |
| dc.contributor.author | Coyle, Vicky M. | |
| dc.contributor.author | McArt, Darragh | |
| dc.contributor.author | Murray, Graeme L. | |
| dc.contributor.author | Samuel, Leslie | |
| dc.contributor.author | Nuciforo, Paolo | |
| dc.contributor.author | Jimenez, Jose | |
| dc.contributor.author | Argiles, Guillem | |
| dc.contributor.author | Dienstmann, Rodrigo | |
| dc.contributor.author | Tabernero, Josef | |
| dc.contributor.author | Picariello, Lucia | |
| dc.contributor.author | Messerini, Luca | |
| dc.contributor.author | Nobili, Stefania | |
| dc.contributor.author | Mini, Enrico | |
| dc.contributor.author | Sheahan, Kieran | |
| dc.contributor.author | Ryan, Elizabeth | |
| dc.contributor.author | Johnston, Patrick G. | |
| dc.contributor.author | Van Schaeybroeck, Sandra | |
| dc.contributor.author | Lawler, Mark | |
| dc.contributor.author | Longley, Daniel B. | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.date.accessioned | 2018-06-20T23:08:53Z | |
| dc.date.available | 2018-06-20T23:08:53Z | |
| dc.date.issued | 2018-06-13 | |
| dc.description | This work was funded by Cancer Research UK: C212/A13721 and C11884/A24387 | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 15 | |
| dc.format.extent | 1148092 | |
| dc.identifier | 118877019 | |
| dc.identifier | a637df67-9870-4c9a-999c-cce4c8d63f49 | |
| dc.identifier | 85083938497 | |
| dc.identifier | 30088816 | |
| dc.identifier.citation | Allen, W L, Dunne, P D, McDade, S, Scanlon, E, Loughrey, M, Coleman, H G, McCann, C, McLaughlin, K, Nemeth, Z, Syed, N A, Jithesh, P V, Arthur, K, Wilson, R, Coyle, V M, McArt, D, Murray, G L, Samuel, L, Nuciforo, P, Jimenez, J, Argiles, G, Dienstmann, R, Tabernero, J, Picariello, L, Messerini, L, Nobili, S, Mini, E, Sheahan, K, Ryan, E, Johnston, P G, Van Schaeybroeck, S, Lawler, M & Longley, D B 2018, 'Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy', JCO Precision Oncology, vol. 2, pp. 1-15. https://doi.org/10.1200/PO.17.00241 | en |
| dc.identifier.doi | 10.1200/PO.17.00241 | |
| dc.identifier.issn | 2473-4284 | |
| dc.identifier.other | ORCID: /0000-0002-8402-8670/work/50559782 | |
| dc.identifier.other | ORCID: /0000-0003-3981-2420/work/76973564 | |
| dc.identifier.other | PubMedCentral: PMC6040635 | |
| dc.identifier.uri | http://hdl.handle.net/2164/10636 | |
| dc.identifier.vol | 2 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | JCO Precision Oncology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
| dc.subject | Cancer Research UK | en |
| dc.subject | C212/A13721 | en |
| dc.subject | C11884/A24387 | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | RC0254 | en |
| dc.title | Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy | en |
| dc.type | Journal article | en |
